Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Long-Term Deferred Tax (2022 - 2023)

Spruce Biosciences (SPRB) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $249000.0 as the latest value for Q4 2023.

  • Quarterly Long-Term Deferred Tax fell 99.51% to $249000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $249000.0 through Dec 2023, down 99.51% year-over-year, with the annual reading at $249000.0 for FY2023, 99.51% down from the prior year.
  • Long-Term Deferred Tax for Q4 2023 was $249000.0 at Spruce Biosciences, down from $50.8 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $50.8 million in Q4 2022, with the low at $249000.0 in Q4 2023.